---
title: "Lufax's 20-Month Hiatus Ends as Hong Kong's Niche Stocks Chart Divergent Paths"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301013239.md"
description: "Lufax Holding (661.HK) resumed trading on September 24 after a 20-month suspension, plunging 40.83% at open. Meanwhile, CHABAIDAO (2555.HK) expanded to 130+ overseas stores while Tigermed (3347.HK) partnered with DiAn Diagnostics on AI-driven drug development, highlighting stark contrasts in Hong Kong's small-cap segment."
datetime: "2026-10-06T09:17:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301013239.md)
  - [en](https://longbridge.com/en/news/301013239.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301013239.md)
generator: "portal-rs"
---

# Lufax's 20-Month Hiatus Ends as Hong Kong's Niche Stocks Chart Divergent Paths

Hong Kong's niche equities are undergoing a quiet transformation as fundamental shifts reshape market dynamics. Lufax Holding (661.HK) marked a watershed moment on September 24 after resuming trading following a 20-month suspension—the longest in recent Hong Kong market history. The fintech platform's shares plunged 40.83% at open amid pent-up selling pressure, though its successful resolution of six HKEX-mandated compliance requirements signals improved governance.

The consumer sector tells a different story. CHABAIDAO (2555.HK) has quietly built an international footprint with over 130 overseas stores across 13 markets, including a landmark Louvre Carrousel location in Paris. CEO Wang Huan emphasized the 'long-term investment with landmark value' strategy, driving first-half revenue growth of 6.21% despite challenging domestic conditions.

In healthcare, Tigermed (3347.HK) forged a strategic alliance with DiAn Diagnostics on September 30 to integrate AI-powered drug discovery with companion diagnostics. The move comes as Goldman Sachs initiated coverage with a 'Buy' rating, citing the company's leadership in China's clinical CRO market. Similarly, China Coal Energy (1898.HK) is pivoting toward renewable integration, establishing a new energy subsidiary in Anhui province with 1.5 billion yuan capitalization.

Technology players are pursuing specialized breakthroughs. MeiG Smart (3268.HK) accelerated its AI edge computing initiatives through partnerships with Feikuo Technology, targeting embodied robotics applications. Solomon Systech (2878.HK) reported H1 losses but maintained 27.4% gross margin through product portfolio optimization. China Daye Non-Ferrous Metals Mining (6623.HK) turned profitable with 458 million yuan net income as copper prices surged.

Market observers note contrasting trajectories: Nanshan Aluminium International (2610.HK) revised upward its related-party transaction limits, while ETF products (3076.HK, 3433.HK) remain sidelined. As liquidity concentrates on fundamentally sound names, this divergence may define Hong Kong's small-cap landscape through 2026.

### Related Stocks

- [00661.HK](https://longbridge.com/en/quote/00661.HK.md)
- [02555.HK](https://longbridge.com/en/quote/02555.HK.md)
- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [01898.HK](https://longbridge.com/en/quote/01898.HK.md)
- [03268.HK](https://longbridge.com/en/quote/03268.HK.md)
- [02878.HK](https://longbridge.com/en/quote/02878.HK.md)
- [06623.HK](https://longbridge.com/en/quote/06623.HK.md)
- [02610.HK](https://longbridge.com/en/quote/02610.HK.md)
- [03076.HK](https://longbridge.com/en/quote/03076.HK.md)
- [03433.HK](https://longbridge.com/en/quote/03433.HK.md)

## Related News & Research

- [Hangzhou Tigermed Files HKEX Next-Day Disclosure Return Announcing Share Buyback](https://longbridge.com/en/news/306242433.md)
- [Tigermed Board Proposes Amendments to Articles of Association](https://longbridge.com/en/news/306168258.md)
- [Hangzhou Tigermed Announces Extraordinary General Meeting](https://longbridge.com/en/news/305816569.md)
- [Tigermed Adds Proposed Articles Amendments to December EGM Agenda](https://longbridge.com/en/news/306169377.md)
- [Hangzhou Tigermed Files HKEX Next-Day Disclosure Return on Share Buyback](https://longbridge.com/en/news/306088139.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**